Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00681382 |
This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.
Condition |
---|
Asthma |
Study Type: | Observational |
Study Design: | Case-Only, Cross-Sectional |
Official Title: | INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland |
Enrollment: | 142 |
Study Start Date: | October 2006 |
Study Completion Date: | April 2007 |
Groups/Cohorts |
---|
1
Asthma patients using inhaled steroids as maintenance treatment
|
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Primary care clinic
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | AstraZeneca ( Klaus Tamminen - MC Medical Director ) |
Study ID Numbers: | NIS-RFI-SYM-2006/1 |
Study First Received: | May 19, 2008 |
Last Updated: | May 21, 2008 |
ClinicalTrials.gov Identifier: | NCT00681382 |
Health Authority: | Finland: Ethics Committee |
Asthma use of asthma medication asthma control telephone survey patient's perception |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases |
Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |
Immune System Diseases Bronchial Diseases |